Modification of erythropoietin structure by N‐homocysteinylation affects its antiapoptotic and proliferative functions
Open Access
- 13 August 2018
- journal article
- research article
- Published by Wiley in The FEBS Journal
- Vol. 285 (20) , 3801-3814
Abstract
Many patients under therapy with recombinant human erythropoietin (rhuEPO) show resistance to the treatment, an effect likely associated with the accumulation of tissue factors, especially in renal and cardiovascular diseases. Hyperhomocysteinemia due to high serum levels of homocysteine has been suggested among the risk factors in those pathologies. Its main effect is the N‐homocysteinylation of proteins due to the interaction between the highly reactive homocysteine thiolactone (HTL) and lysine residues. The aim of this study was to evaluate the effect of N‐homocysteinylation on the erythropoietic and antiapoptotic abilities of EPO, which can be a consequence of structural changes in the modified protein. We found that both cellular functions were altered in the presence of HTL‐EPO. A decreased net positive charge of HTL‐EPO was detected by capillary zone electrophoresis, while analysis of polyacrylamide gel electropherograms suggested formation of aggregates. Far‐UV spectra, obtained by Circular Dichroism Spectroscopy, indicated a switch of the protein's secondary structure from α‐helix to β‐sheet structures. Results of Congo red and Thioflavin T assays confirm the formation of repetitive β‐sheet structures, which may account for aggregates. Accordingly, Dynamic Light Scattering analysis showed a markedly larger radius of the HTL‐EPO structures, supporting the formation of soluble oligomers. These structural changes might interfere with the conformational adaptations necessary for efficient ligand‐receptor interaction, thus affecting the proliferative and antiapoptotic functions of EPO. The present findings may contribute to explain the resistance exhibited by patients with cardio‐renal syndrome to treatment with rhuEPO, as a consequence of structural modifications due to protein N‐homocysteinylation.Keywords
Funding Information
- Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET 11220150100804CO)
- Agencia Nacional de Promoción Científica y Tecnológica (ANPCYT‐PICT 13‐0692)
- Universidad de Buenos Aires (UBACYT 200201301100246BA)
This publication has 43 references indexed in Scilit:
- Ordered Self-Assembly Mechanism of a Spherical Oncoprotein Oligomer Triggered by Zinc Removal and Stabilized by an Intrinsically Disordered DomainPLOS ONE, 2012
- Vascular Incompetence in Dialysis Patients—Protein‐Bound Uremic Toxins and Endothelial DysfunctionSeminars in Dialysis, 2011
- Homocysteine or Renal ImpairmentArteriosclerosis, Thrombosis, and Vascular Biology, 2008
- Role of erythropoietin in the brainCritical Reviews in Oncology/Hematology, 2007
- A quasi‐spontaneous amyloid route in a DNA binding gene regulatory domain: The papillomavirus HPV16 E2 proteinProtein Science, 2007
- Biophysical Comparability of the Same Protein From Different Manufacturers: A Case Study Using Epoetin Alfa From Epogen® and Eprex®Journal of Pharmaceutical Sciences, 2006
- Increased plasma protein homocysteinylation in hemodialysis patientsKidney International, 2006
- Modification of Fibrinogen by Homocysteine Thiolactone Increases Resistance to Fibrinolysis: A Potential Mechanism of the Thrombotic Tendency in HyperhomocysteinemiaBiochemistry, 2006
- Erythropoietin Unfolding: Thermodynamics and Its Correlation with Structural FeaturesBiochemistry, 2005
- The distinct erythropoietin functions that promote cell survival and proliferation are affected by aluminum exposure through mechanisms involving erythropoietin receptorBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2005